We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Overused Antibiotics in Food Animals Pose Threats

By HospiMedica staff writers
Posted on 20 Jan 2005
New research shows that antibiotic-resistant urinary tract infections (UTIs) that can lead to trips to the emergency department may be a result of the overuse of antibiotics in food animals, according to a study reported in the January 15, 2005, issue of Clinical Infectious diseases.

Researchers identified Escherichia coli from animal guts that are highly similar to the multidrug-resistant bacteria previously associated with an outbreak of urinary tract infections in women in California. More...
This identification of the bacteria in food animals strengthens the case that multidrug-resistant UTIs have a food-animal origin. The research was conducted by experts at the School of Public Health of the University of California at Berkeley (USA).

Food animals are routinely given the same antibiotics that doctors use to treat humans, such as sulfa drugs and penicillin. Enormous quantities of these drugs are used. Research by the Union of Concerned Scientists (UCS, Washington, DC, USA) estimates that more than 13 million pounds of such drugs are used every year in swine, poultry, and cattle--not for therapy but to promote growth and well-being in the stressful crowded conditions that are typical of industrial agriculture.

"When urinary infections do not respond to standard antibiotic treatments, the delays in finding an effective antibiotic can prolong the course of the disease and sometimes lead to trips to the emergency room,” noted Dr. Margaret Mellon, director of the Food and Agriculture Program at the UCS.




Related Links:
U. California, Berkeley

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.